Theravance Biopharma (TBPH) Stock Chart & Stock Price History $11.00 -0.12 (-1.08%) As of 02:13 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Theravance Biopharma Stock Price Performance The Theravance Biopharma (TBPH) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 27.46%, with a year-to-date return of 16.90%. In the past month, the stock has increased 6.08%, reflecting recent market activity. As of the latest close, Theravance Biopharma traded at $11.12 with a market cap of $556.01 million and volume of 717,216 shares. Five years ago, the stock traded at $26.64, representing a 58.71% decrease over that period. At the time, it had a market cap of $1.68 billion and a volume of 644,200 shares. Receive TBPH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Theravance Biopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+18.92%1 Month Performance+6.08%3 Month Performance+20.88%Year-To-Date Performance+16.90%1 Year Performance+27.46%5 Year Performance-58.71% TBPH Stock Chart for Wednesday, June, 4, 2025 TBPH Chart by TradingView Theravance Biopharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/03/2025$11.15$11.12-0.27%$11.82$11.00717,216 shs$556.01 million06/02/2025$9.25$11.15+20.54%$11.21$9.981.81 million shs$557.51 million05/30/2025$9.30$9.25-0.54%$9.36$9.16200,660 shs$462.51 million05/29/2025$9.15$9.30+1.64%$9.45$9.10127,572 shs$465.01 million05/28/2025$9.28$9.15-1.40%$9.35$9.12156,274 shs$457.51 million05/27/2025$9.30$9.28-0.22%$9.47$9.22170,750 shs$464.01 million05/26/2025$9.30$9.30$9.53$9.26187,157 shs$465.01 million05/23/2025$9.49$9.30-2.00%$9.53$9.26187,157 shs$465.01 million05/22/2025$9.41$9.49+0.85%$9.60$9.26280,908 shs$474.51 million05/21/2025$9.45$9.41-0.42%$9.47$9.22323,480 shs$470.51 million Get the Latest News and Ratings for TBPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Theravance Biopharma and its competitors with MarketBeat's FREE daily newsletter. 05/20/2025$9.39$9.45+0.64%$9.50$9.20199,922 shs$472.51 million05/19/2025$9.20$9.39+2.07%$9.43$9.07292,754 shs$469.51 million05/16/2025$9.14$9.20+0.66%$9.37$9.04288,747 shs$460.01 million05/15/2025$8.41$9.14+8.68%$9.15$8.40360,884 shs$457.01 million05/14/2025$8.91$8.41-5.61%$9.09$8.33283,138 shs$420.51 million05/13/2025$8.80$8.91+1.25%$8.98$8.73365,641 shs$445.51 million05/12/2025$8.91$8.80-1.23%$9.16$8.75417,517 shs$440.01 million05/09/2025$9.90$8.91-10.00%$9.35$8.69668,121 shs$445.51 million05/08/2025$9.99$9.90-0.90%$10.04$9.64342,990 shs$495.01 million05/07/2025$10.09$9.99-0.99%$10.27$9.98262,330 shs$499.51 million05/06/2025$10.29$10.09-1.94%$10.41$9.90316,642 shs$504.51 million05/05/2025$10.37$10.29-0.77%$10.41$10.10231,704 shs$514.51 million Related Companies AAPG Stock Price Chart NAMS Stock Price Chart BLTE Stock Price Chart HRMY Stock Price Chart KNSA Stock Price Chart VERA Stock Price Chart GMTX Stock Price Chart LGND Stock Price Chart GLPG Stock Price Chart FOLD Stock Price Chart Receive TBPH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Theravance Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TBPH) was last updated on 6/4/2025 by MarketBeat.com Staff From Our PartnersFPV Drone Innovator Secures Major Defense ContractIn May, Ukraine launched Operation Spider Web - a 117-drone FPV swarm that devastated Russian fuel depots and ...The Tomorrow Investor | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredJunior Explorer Taps Into TSMC’s $165 Billion Chip CorridorThe chip war is moving underground. As the U.S. ramps up semiconductor production to outpace China, an unex...Capital Trends | SponsoredThe Recession Already Started, Are You Prepared?Global central banks are stockpiling gold. Billionaires are hedging with precious metals. And thousands of Ame...Lear Capital | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theravance Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Theravance Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TBPH Stock Free TBPH Stock Alerts